Contact

Board of Directors

Galenica’s Board of Directors consists of six members and has ultimate responsibility for the company and its subsidiaries’ business and affairs. The Board of Directors is composed of highly experienced experts and personalities with decades of industry experience and extensive knowledge about the Galenica business.

Dr. Jörg Kneubühler
Chairman of the Board of Directors

  • Elected since 2017
  • Born 1960, Swiss citizen
  • Dr. rer. pol., University of Bern
  • Held various positions in finance at the Swatch Group before joining Galenica
  • Joined the Galenica Group in 2002 as Head of Finance and Administration at Vifor Pharma; Head of Controlling for the Galenica Group as of 2006; Head Corporate Finance and Controlling for the Galenica Group and member of the Corporate Executive Committee since 2009; CFO since 2012 and Head Human Resources from 2012 until August 2014; from 2014 until end of 2016 CFO Galenica Group and CEO Galenica Santé

Daniela Bosshardt-Hengartner

  • Elected since 2017
  • Born 1972, Swiss citizen
  • Pharmacist, Federal Diploma in Pharmacy, Federal Institute of Technology, Zurich
  • Financial analyst at Bank am Bellevue (1998-2002) and M2 Capital (2003-2004)
  • Management consultant in the pharmaceutical, medical technology and biotechnology sectors since 2004
  • Member of the Board of Directors Galenica Group since 2008
  • Member of the Board of Directors of RepRisk AG (Zurich)
  • Member of the Board of Directors of investiere.ch since 2017

Prof. Dr. Michel Burnier

  • Elected since 2017
  • Born 1953, Swiss citizen
  • Swiss-registered Doctor of Internal Medicine and Nephrology
  • University Lecturer, University of Lausanne
  • Member of the Medicines Committee of the Swiss Association of Pharmacists (until 2001), the Board of Swissmedic (2002-2010) and the Board of Directors of Speedel Holding Ltd. (2007-2009)
  • Member of the following organisations: Swiss Society of Nephrology (former President), Scientific Council of the European Society of Hypertension (Treasurer) and Swiss Society of Hypertension (former President)
  • Member of the Board of Directors Galenica Group since 2010

Fritz Hirsbrunner

  • Elected since 2017
  • Born 1949, Swiss citizen
  • Lic. oec., HEC University of Lausanne/Senior Executive Program, IMD, Lausanne
  • 1972–1977 Controller at Ciba-Geigy
  • Joined the Galenica Group in 1977 as Assistant to the Corporate Executive Committee; CFO and member of the Corporate Executive Committee from 1992 to 2011; from 2009 Deputy CEO and CFO; Head Investor Relations until 2014
  • Member of the Board of Directors of Berlac AG, Sissach, and IVF Hartmann Holding AG, Neuhausen, Member of the Board of Trustees of IST Investmentstiftung, Zurich
  • Member of the Board of Directors of VenCap 6 Ltd., Jersey
  • Member of the Board of Directors Galenica Group since 2012

Dr. Philippe Nussbaumer

  • Elected since 2017
  • Born in 1969, Swiss citizen
  • FPH Pharmacist, Fed. Diploma / PhD in Pharm. Sciences, University of Geneva / dipl. oec. HEC, University of Lausanne
  • Director of the Pharmacie Centrale and the Pharmacie de la Gare in La Chaux-de-Fonds and of Veripharm SA
  • Since 2007, founder and director of the ECOPHARMA pharmacy brand
  • Since 2014, founder and director of the Medi-Centre SA medical centre (La Chaux-de-Fonds)
  • Since 2004, Vice-President of Swiss Ski School Neuchâtel-Les Bugnenets

Dr. Andreas Walde

  • Elected since 2017
  • Born 1962, Swiss citizen
  • Attorney-at-law and doctorate in law, University of Basel
  • Various legal and management positions in the chemical and pharmaceutical industry for 25 years 1988-1996 Roche, 1998-2010 Clariant and 2012-2013 Petroplus, in the two latter ones as group general counsel
  • Since 2013 General Secretary of the Galenica Group
  • Former positions include memberships on the boards of several private and (non-Swiss) public listed companies as well as on the board of the Society of Swiss Enterprises in Germany